Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 22,813 | 17,299 | 15,217 | 12,715 | 17,418 |
| Cost of Goods | 3,028 | 2,673 | 2,475 | 2,146 | 2,391 |
| Gross Profit | 19,785 | 14,626 | 12,742 | 10,569 | 15,027 |
| Operating Expenses | 24,097 | 18,331 | 17,118 | 11,360 | 14,382 |
| Operating Income | -4,284 | -3,032 | -3,901 | -645 | 1,036 |
| Interest Expense | 0 | 395 | 706 | 769 | 764 |
| Other Income | 4 | -1,378 | 18 | 38 | 298 |
| Pre-tax Income | -4,280 | -4,805 | -4,589 | -1,376 | 570 |
| Net Income Continuous | -4,280 | -4,889 | -4,589 | -1,376 | 570 |
| Net Income | $-4,280 | $-4,889 | $-4,589 | $-1,376 | $570 |
| EPS Basic Total Ops | -0.17 | -0.26 | -0.23 | -0.08 | 0.03 |
| EPS Basic Continuous Ops | -0.17 | -0.27 | -0.23 | -0.08 | 0.03 |
| EPS Diluted Total Ops | -0.17 | -0.26 | -0.23 | -0.08 | 0.03 |
| EPS Diluted Continuous Ops | -0.17 | -0.27 | -0.23 | -0.08 | 0.03 |
| EBITDA(a) | $-4,051 | $-2,699 | $-3,568 | $-315 | $1,351 |